Health Care REIT Inc. (HCN) Financials Nov 20, 2014, 4:33
Health Care REIT Inc. (HCN) Financials Nov 20, 2014, 4:33 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Health Care REIT Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 568.23M 675.43M 1.42B 1.82B 2.88B
Total Investment Income - - - - -
Sundry Revenue/Income 527.35M 634.58M 1.38B 1.78B 2.85B
Trading Account Income - - - - -
Trust Income, Commissions & Fees - - - - -
Commission & Fee Income - - - - -
Total Expense 381.39M 563.22M 1.26B 1.58B 2.78B
Total Interest Expense 107.2M 154.86M 320.18M 365.49M 456.45M
Depreciation & Amortization Expense 178.62M 216.86M 437.12M 548.77M 882.52M
Other Operating Expense 0 46.66M 70.22M 1.6M 137.87M
2009 2010 2011 2012 2013 5-year trend
Operating Income 186.85M 112.21M 155.45M 246.49M 101.34M
Non-Operating Income (Expense) 0 0 0 0 0
Non-Operating Interest Income 0 0 0 0 0
Miscellaneous Non Operating Expense 0 0 0 0 0
Equity in Affiliates (Pretax) 0 - - 0 -
Unusual Expense 25.11M 34.17M (979,000) 60.83M (909,000)
Pretax Income 161.74M 78.04M 156.43M 185.65M 102.25M
Income Taxes 168,000 364,000 1.39M 7.61M 7.49M
Income Tax - Current - Domestic - - - 4.79M 12.39M
Income Tax - Current - Foreign - - - - -
Income Tax - Deferred - Domestic - - - 2.83M (4.9M)
Income Tax - Deferred - Foreign - - - - -
Income Tax Credits - - - 0 0
Equity in Affiliates 0 6.67M 5.77M 2.48M (8.19M)
Other After Tax Income (Expense) 0 0 0 (6.24M) 0
Consolidated Net Income 161.57M 84.35M 160.81M 174.28M 86.57M
Minority Interest Expense (342,000) 357,000 (4.89M) (2.42M) (6.77M)
Net Income 161.91M 84M 165.71M 176.7M 93.34M
Extraordinaries & Discontinued Operations 31.36M 44.53M 51.9M 114.32M 51.71M
Extra Items & Gain/Loss Sale Of Assets 43.39M 36.12M 61.16M 100.55M 49.14M
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations (12.04M) 8.42M (9.26M) 13.77M 2.58M
Net Income After Extraordinaries 130.56M 39.46M 113.8M 62.38M 41.62M
Preferred Dividends 22.08M 21.65M 60.5M 69.13M 66.34M
Net Income Available to Common 139.83M 62.35M 105.21M 107.57M 27M
EPS (Basic) 1.12 0.55 0.55 0.54 0.11
Basic Shares Outstanding 114.21M 127.66M 173.74M 224.34M 276.93M
EPS (Diluted) 1.12 0.55 0.55 0.54 0.11
Diluted Shares Outstanding 114.61M 128.21M 174.4M 225.95M 278.76M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...
Continue Reading
Wood Finishes and the Warm Embrace Alright folks, let's cut through the fluff and get to the heart of the matter: wood finishes are making a roaring comeback in 2027 kitchens. And it's not just some passing phase, we're talking a comprehensive shift toward warmer and more natural kitchen designs. MasterBrand, Inc. isn't just throwing darts at a board here. They surveyed a...
Continue Reading
Control Dialed In: Tailored Call Screening Kicking things up a notch, Mutare is redefining call security by fine-tuning their Voice Security for Webex Calling. Imagine this—custom rules now let organizations shape a security policy down to the very last detail, ensuring unwanted calls don’t slip through the cracks. Wave goodbye to the broad-strokes approach. Precision...
Continue Reading
Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...
Continue Reading
Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...
Continue Reading
Expanding Horizons in Hillsboro In the world of postal and office services, Annex Brands, Inc. is making headlines by launching yet another Postal Connections spot, this time planting its flag in the tech-centric town of Hillsboro, Oregon. Spearheaded by Jason Rautenkranz, this expansion is more than just another dot on a map—it's a strategic push into one of the...
Continue Reading
A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...
Continue Reading
Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...
Continue Reading
Union Square Becomes a Hub of Interactivity The heart of NYC pulsed with purpose as FC2 Female Condom set up shop in Union Square, using the iconic location as a stage for a different kind of celebration. Clear Future, the manufacturer behind FC2, marked Global Female Condom Day with an event unlike any other. It wasn't just about the product—it was a call to educate...
Continue Reading
Backing Up: New Paths for Proxmox Users Ever get that feeling of uncovering something truly worth its weight in gold? That's what MSP360 just dropped on us, with their new backup solution for Proxmox that won’t cost you a dime upfront. They're calling it the Community Edition, and it’s not only free, but it comes with all the bells and whistles for protecting those...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of the Human-Machine Interface Market The global human-machine interface (HMI) market is currently valued at about USD 4.07 billion and is expected to grow significantly, possibly reaching USD 10.64 billion within the next decade. This remarkable growth reflects a compound annual growth rate (CAGR) of 10.1%. The importance of Human-Machine Interfaces stems from...
Continue Reading
Leadership Transition at Mattel, Inc. Mattel, Inc. (NASDAQ: MAT), the recognized leader in toy production, has announced a significant transition within its executive team as its Chief Financial Officer, Anthony DiSilvestro, has plans to retire. The planned retirement is set for May, with the company actively searching for DiSilvestro's successor. The transition strategy...
Continue Reading
Groundbreaking Steps in Cancer Treatment with REC-3565 Recursion, a trailblazer in the TechBio realm, has announced an exciting new development: the first patient has been dosed in a Phase 1 clinical study of REC-3565, a selective MALT1 inhibitor aimed at treating relapsed or refractory B-cell lymphomas. This endeavor signifies a pivotal moment in the realm of...
Continue Reading
Legal Challenges Faced by Dow Inc. As one of the leading companies in materials science solutions, Dow Inc. (NYSE: DOW) is currently facing significant legal challenges that are affecting its investors. The ongoing situation involves a class action lawsuit aimed at protecting shareholders who bought Dow securities between late January and late July. The legal proceedings...
Continue Reading
Palvella Therapeutics Appoints New Chief Innovation Officer Palvella Therapeutics, Inc. has recently announced the appointment of Dr. David W. Osborne as their Chief Innovation Officer. With over 25 years of exceptional experience in the pharmaceutical industry, Dr. Osborne brings a wealth of knowledge in developing innovative therapies for serious, rare genetic skin...
Continue Reading